Sandoz resolves legacy federal government civil investigation regarding generic drugs
Sandoz will pay $185 million, plus interest from the date of the agreement in principle to settle, and has agreed to corporate integrity obligations with the Office of Inspector General of the U.S. Department of Health & Human Services through 2026.